Targeted Biologic Therapy for Pediatric and Adult Patients With Moderate to Severe AD

Targeted Biologic Therapy for Pediatric and Adult Patients With Moderate to Severe AD

Updates in Eosinophilic Esophagitis: Underlying Mechanisms and Novel Targeted TherapyПодробнее

Updates in Eosinophilic Esophagitis: Underlying Mechanisms and Novel Targeted Therapy

Using Biologics to Manage Moderate to Severe Atopic DermatitisПодробнее

Using Biologics to Manage Moderate to Severe Atopic Dermatitis

Atopic Dermatitis: Strategies to Improve Outcomes (Adult: Moderate-Severe)Подробнее

Atopic Dermatitis: Strategies to Improve Outcomes (Adult: Moderate-Severe)

2021 Pediatric Grand Rounds: “An Update on Pediatric Inflammatory Bowel Disease” (October 29,2021)Подробнее

2021 Pediatric Grand Rounds: “An Update on Pediatric Inflammatory Bowel Disease” (October 29,2021)

Uncontrolled, Moderate to Severe Asthma: Identifying Eligible Patients for Targeted Biologic TherapyПодробнее

Uncontrolled, Moderate to Severe Asthma: Identifying Eligible Patients for Targeted Biologic Therapy